The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?

被引：1
|
作者：
King, Christopher S. [1 ]
Cochrane, Adam B. [2 ]
机构：
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Clin, 618 S Royal St, Falls Church, VA 22314 USA
[2] Inova Fairfax Hosp, Adv Lung Dis Clin, Dept Pharm, Falls Church, VA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 09期
关键词：
BRONCHIOLITIS OBLITERANS SYNDROME; MEDIATED REJECTION; INTERNATIONAL SOCIETY; HLA-ANTIBODIES; HEART;
D O I：
10.1016/j.healun.2016.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1057 / 1058
页数：2
相关论文
共 50 条
  • [1] DE NOVO DONOR-SPECIFIC ANTIBODIES (DSA) AND THEIR IMPACT ON OUTCOMES IN LUNG TRANSPLANTATION
    Enrica, Pacquola
    Elisa, Trovato Salinaro
    Daniela, Zanotto
    Fabio, Agusson
    Laura, del Giudice
    Monica, Loy
    Arianna, Veronesi
    Giustina, De Silvestro
    HLA, 2019, 93 (05) : 309 - 310
  • [2] Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Alagusundaramoorthy, Sayee
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Sollinger, Hans
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier
    TRANSPLANTATION, 2019, 103 (02) : 435 - 440
  • [3] Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients
    Razia, Deepika
    Hu, Chengcheng
    Cherrier, Lauren
    Nasar, Aasya
    Walia, Rajat
    Tokman, Sofya
    TRANSPLANT IMMUNOLOGY, 2022, 75
  • [4] PERSISTENT DE NOVO DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH DECREASED SURVIVAL IN LUNG TRANSPLANT RECIPIENTS
    Kauke, Teresa
    Schmitzer, Magdalena
    Kneidinger, Nikolaus
    Neurohr, Claus
    Schramm, Rene
    Von Dossow, Vera
    Winter, Hauke
    TRANSPLANT INTERNATIONAL, 2017, 30 : 33 - 33
  • [5] Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
    Islam, Ana K.
    Sinha, Neeraj
    DeVos, Jennifer M.
    Kaleekal, Thomas S.
    Jyothula, Soma S.
    Teeter, Larry D.
    Nguyen, Duc T. M.
    Eagar, Todd N.
    Moore, Linda W.
    Puppala, Mamta
    Wong, Stephen T. C.
    Knight, Richard J.
    Frost, Adaani E.
    Graviss, Edward A.
    Gaber, A. Osama
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [6] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES: BIOMARKERS OF PANCREAS TRANSPLANT FAILURE
    Mittal, Shruti
    Page, Suzanne L.
    Gilbert, James
    Friend, Peter J.
    Sharples, Edward
    Fuggle, Susan V.
    TISSUE ANTIGENS, 2013, 81 (05): : 274 - 274
  • [7] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
  • [8] The Impact of Pre-Formed Donor-Specific HLA Antibodies on Early Clinical Outcomes in Lung Transplant Recipients
    Fujimoto, K.
    Shigemura, N.
    Sareyyupoglu, B.
    Bonsal, A.
    Minakata, K.
    Shayan, H.
    Ota, T.
    Bhama, J.
    Bonde, P.
    Thacker, J.
    Bermudez, C.
    Zaldonis, D.
    Zeevi, A.
    Toyoda, Y.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S37 - S37
  • [9] TRANSPLANT OUTCOMES IN PATIENTS WITH DE NOVO DONOR SPECIFIC ANTIBODIES POST TRANSPLANT
    Pochinco, Denise
    Kelm, Dawn
    Kendra, Hacking
    Blydt-Hansen, Tom
    Rush, David
    Gibson, Ian
    Nickerson, Peter
    HUMAN IMMUNOLOGY, 2009, 70 : S65 - S65
  • [10] De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation
    Cole, Robert Townsend
    Gandhi, Jonathan
    Bray, Robert A.
    Gebel, Howard M.
    Morris, Alanna
    McCue, Andrew
    Yin, Michael
    Laskar, S. Raja
    Book, Wendy
    Jokhadar, Maan
    Smith, Andrew
    Duc Nguyen
    Vega, J. David
    Gupta, Divya
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
12345